Comparative in Vitro Activity of Levofloxacin, Ofloxacin, and Ciprofloxacin Against Ocular Streptococcal Isolates

Cornea

Volumn 23, Issue 3, 2004, Pages 289-293

  Miller, Darlene ^a   Alfonso, Eduardo C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Endophthalmitis; Fluoroquinolone; Levofloxacin; Minimal inhibitory concentration; Streptococcus; Susceptibility

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN; PENICILLIN G;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENDOPHTHALMITIS; KERATITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; ENDOPHTHALMITIS; HUMANS; KERATITIS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; STREPTOCOCCUS PNEUMONIAE; VIRIDANS STREPTOCOCCI;

EID: 1642463916     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200404000-00012     Document Type: Article

References (17)

1. Song A, Scott IU, Flynn BW Jr, et al. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109:985-991.
2. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000;107:1497-1502.
3. Jones RN, Wilson WR. Epidemiology, laboratory detection and therapy of penicillin-resistant streptococcal infections. Diag Microbiol Infect Dis. 1998;31:453-459.
4. Brueggemann AB, Coffman SL, Rhomberg P, et al. Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995. Antimicrob Agents Chemother. 2002;46:680-688.
5. Doern GV, Heilman KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 2001;45:1721-1729.
6. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999;106:1313-1318.
7. Callegan MC, Booth MC, Gilmore MS. In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens. Cornea. 2000;19:539-545.
8. Song A, McCulley TJ, Lam BL, et al. Pseudomonas aeruginosa in vitro corneal isolate sensitivity to ofloxacin, ciprofloxacin, and trovafloxacin: a comparative study. Am J Ophthalmol. 2001;131:795-796.
9. Graves A, Henry M, O'Brien TP, et al. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones. Cornea. 2001;20:301-305.
10. Kowalski RP, Pandya AN, Karenchak LM, et al. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Stapoylococcus aureus and Pseudomonas aeruginosa. Ophthalmology. 2001;108:1826-1829.
11. Hoban DJ, Bouchillon SK, Johnson JL, et al. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study. Diag Microbiol Infect Dis. 2001;40:51-57.
12. Hoban DJ, Bouchillon SK, Johnson JL, et al. Comparative in vitro potency of gemifloxacin and fluoroquinolones against recent European clinical isolates from a global surveillance study. Eur J Clin Microbiol Infect Dis. 2001;20:814-819.
13. White RL, Enzweiler KA, Friedrich LV, et al. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae during 1999-2000. Diag Microbiol Infect Dis. 2002;43:207-217.
14. Gunderson BW, Ross GH, Ibrahim KH, et al. What do we really know about antibiotic pharmacodynamics? Pharmacotherapy, 2001;21:302s-318s.
15. Lumberg M, Bugge C. Tear concentrations of topically applied ciprofloxacin. Cornea. 1994;13:496-499.
16. Ross DL, Riley CM. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharmaceutics. 1990;63:237-250.
17. Garcia-Saenz MC, Arias-Puente A, Fresnadillo-Martinez MJ, et al. Human aqueous humor levels or oral ciprofioxacin, levofloxacin, and moxifloxacin. J Cataract Refract Surg. 2001;12:1969-1974.